DiaSorin, Inc.: FDA filings under this applicant name

FDA lists 71 510(k) clearances under 2 spellings of the applicant name “DiaSorin, Inc.” (first 1998, latest 2026), plus 23 PMA and 1 De Novo decisions, across 43 product codes in 4 review panels. Median 510(k) review time under this name: 90 days. Since 2017 the median was 89 days, against 141 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.

510(k) clearances per year

YearClearancesMedian review days
2012276
20131084
20142138
2015254
2016460
2017373
2018388
2019276
2020494
20214167
20223210
20231182
20240—
20250—
2026187

Review time against the same product codes

Since 2017, 510(k)s cleared under the name DiaSorin, Inc. took a median 89 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 141 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
LOLHepatitis A Test (Antibody And Igm Antibody)108
LOMTest, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen)61
MRGSystem, Test, Vitamin D66
LSEEpstein-Barr Virus, Other55
JJXSingle (Specified) Analyte Controls (Assayed And Unassayed)44
LSRReagent, Borrelia Serological Reagent44
SEIQualitative And Quantitative Hepatitis B Virus Antibody Assays40
CEWRadioimmunoassay, Parathyroid Hormone33
DFCLipoprotein, Low-Density, Antigen, Antiserum, Control33
LFXEnzyme Linked Immunoabsorbent Assay, Rubella33

Plus 33 more product codes.

Review panels

Most recent DiaSorin, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K260770LIAISON Murex HBsAg Qual; LIAISON XL; LIAISON diluteXLOM2026-06-0487
K231214LIAISON VZV IgG HT, LIAISON Control VZV IgG HTLFY2023-10-27182
K223403LIAISON Anti-HAV; LIAISON XSLOL2022-12-0930
K213858LIAISON Calprotectin, LIAISON Q.S.E.T. Device PlusNXO2022-07-26228
K213936LIAISON MeMed BV, LIAISON MeMed BV Control SetQPS2022-07-14210
K193650LIAISON FerritinDBF2021-09-14624
K202574LIAISON Lyme IgG, LIAISON Lyme IgG Control Set, LIAISON Lyme Total Antibody PlusLSR2021-02-18167
K202573LIAISON Lyme IgM, LIAISON Lyme IgM Control Set, LIAISON Lyme Total Antibody PlusLSR2021-02-18167
K210272LIAISON Anti-HAVLOL2021-02-098
K201908LIAISON Testosterone xtCDZ2020-10-1598

61 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P250039PMALIAISON Biotrin Parvovirus B19 IgM Plus, LIAISON Biotrin Control Parvovirus B19 IgM Plus2026-05-07
DEN250032De NovoDevice To Detect Antibodies To Hepatitis D Virus2025-12-23
P220034PMALIAISON Biotrin Parvovirus B19 IgG Plus, LIAISON Biotrin Control Parvovirus B19 IgG Plus2024-03-29
P180045PMALIAISON® XL MUREX HBc IgM, LIAISON® XL MUREX Control HBc IgM2020-08-29
P190017PMALIAISON® XL MUREX HBsAg Qual, LIAISON® MUREX Control HBsAg, and LIAISON® XL MUREX HBsAg Confirmatory Test2020-08-29

Recalls

39 product recalls in 39 recall events; 2 initiated in the last five years. Most recent: 2024-11-07.

Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

FDA spellings included

FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:

Other FDA applicant names starting with the same word

FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.

Frequently asked questions

How many FDA 510(k) clearances are listed under DiaSorin, Inc.?

FDA lists 71 510(k) clearances under 2 spellings of the applicant name “DiaSorin, Inc.” (first 1998, latest 2026), plus 23 PMA and 1 De Novo decisions, across 43 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.

How long has FDA taken to clear 510(k)s filed by DiaSorin, Inc.?

The median time from FDA receipt to decision across 510(k)s cleared under the name DiaSorin, Inc. is 90 days. Since 2017: 89 days, versus 141 days for all cleared 510(k)s in the same product codes.

Which FDA product codes appear under DiaSorin, Inc.?

The most frequent FDA product codes under this applicant name are LOL (Hepatitis A Test (Antibody And Igm Antibody), 10); LOM (Test, Hepatitis B (B Antigen, B Surface Antigen, Be Antigen), 6); MRG (System, Test, Vitamin D, 6).

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.

All FDA device companies · FDA product code lookup